Carbonyl Stress in Red Blood Cells and Hemoglobin.
Olga V KosmachevskayaNatalia N NovikovaAlexey F TopunovPublished in: Antioxidants (Basel, Switzerland) (2021)
The paper overviews the peculiarities of carbonyl stress in nucleus-free mammal red blood cells (RBCs). Some functional features of RBCs make them exceptionally susceptible to reactive carbonyl compounds (RCC) from both blood plasma and the intracellular environment. In the first case, these compounds arise from the increased concentrations of glucose or ketone bodies in blood plasma, and in the second-from a misbalance in the glycolysis regulation. RBCs are normally exposed to RCC-methylglyoxal (MG), triglycerides-in blood plasma of diabetes patients. MG modifies lipoproteins and membrane proteins of RBCs and endothelial cells both on its own and with reactive oxygen species (ROS). Together, these phenomena may lead to arterial hypertension, atherosclerosis, hemolytic anemia, vascular occlusion, local ischemia, and hypercoagulation phenotype formation. ROS, reactive nitrogen species (RNS), and RCC might also damage hemoglobin (Hb), the most common protein in the RBC cytoplasm. It was Hb with which non-enzymatic glycation was first shown in living systems under physiological conditions. Glycated HbA1c is used as a very reliable and useful diagnostic marker. Studying the impacts of MG, ROS, and RNS on the physiological state of RBCs and Hb is of undisputed importance for basic and applied science.
Keyphrases
- red blood cell
- reactive oxygen species
- end stage renal disease
- renal cell carcinoma
- chronic kidney disease
- endothelial cells
- arterial hypertension
- cell death
- dna damage
- cardiovascular disease
- type diabetes
- newly diagnosed
- ejection fraction
- public health
- oxidative stress
- prognostic factors
- peritoneal dialysis
- hydrogen peroxide
- glycemic control
- binding protein
- amino acid
- high density
- weight loss
- genetic diversity